Osobennosti korrektsii gipogonadizma u zhenshchin pri khirurgicheskoy menopauze
- Authors: Kalinchenko SY.1, Apetov SS1
-
Affiliations:
- Issue: Vol 13, No 3 (2011)
- Pages: 19-23
- Section: Articles
- URL: https://gynecology.orscience.ru/2079-5831/article/view/28155
- ID: 28155
Cite item
Full Text
Abstract
References
- Hickey M, Ambekar M, Hammond I. Should the ovaries be removed or retained at the time of hysterectomy for benign disease? Hum Reprod Update 2010, 16 (2): 131-41.
- Henderson VW, Sherwin B.B. Surgical versus natural menopause: cognitive issues. Menopause 2007, 14: 572-9.
- Shifren JL, Avis NE. Surgical menopause: effects on psychological well-being and sexuality. Menopause 2007; 14: 586-91.
- Sievers C, Klotsche J, Pieper L et al. Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients. Eur Journ Endocr 2010; 163 (4): 699-708.
- Buster JE, Kingsberg SA, Aguirre О et al. Testosterone patch for low sexual desirein surgically menopausal women: A randomized trial. Obstet Gynecol 2005; 105: 944-52.
- Радзинский В.Е., Калинченко С.Ю., Апетов С.С. Синдром дефицита андрогенов у женщин. Вестник РУДН 2010; 6: 266-76.
- Чеботникова Т.В., Андреева Е.Н. Дефицит андрогенов у женщин - новые возможности тканеселективных модуляторов. Трудный пациент, 2006; 9: 21-9.
- Табеева Г.И., Марченко Л.А., Бутарева Л.Б., Габибуллаева З.Г. Возможности лечения эстроген- и андрогендефицитных состояний у женщин с преждевременной недостаточностью яичников. Гинекология, 2009; 1 (11): 55-9.
- Калинченко С.Ю., Апетов С.С. Применение андрогенов у женщин в климактерическом периоде. Лечащий врач, 2009; 3: 36-8.
- Bachmann GA, Bancroft J, Braunstein G et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification and assessment. Fertil Steril 2002; 77: 660-5.
- Panzer C, Guay A. Testosterone replacement therapy in naturally and surgically menopausal women. J Sex Med 2009; 6: 8-18.
- Michelsen TM, Pripp AH, Tonstad S et al. Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study. Eur J Cancer 2009, 45: 82-9.
- Salpeter SR, Walsh JME, Ormiston TM et al. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diab Obes Metab 2006; 8: 538-54.
- Rosano G, Vitale C, Silvestri A, Fini M. Metabolic and vascular effects of progestins in post-menopausal women. Implications for cardioprotection. Maturitas 2003; 46S: S17-29.
- Chlebowski RT, Hendrix SL, Langer RD et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA 2003; 289: 3243-53.
- Hulley S, Furberg C, Barrett-Connor E et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 2002; 288: 58-64.
- Anderson GL, Chlebowski RT, Rossouw JE et al. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas 2006; 55: 103-15.
- Kenemans P. Postmenopausal hormone therapy and breast cancer: what is the problem? Maturitas 2005; 51: 75-82.
- Schairer C, Lubin J, Troisi R et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000; 283: 485-91.
- Campagnoli C, Clavel-Chapelon F, Kaaks R et al. Progestins and progesterone in hormone replacement therapy and the risk of breast cancer. J Steroid Biochem Mol Biol 2005; 96: 95-108.
- Campagnoli C, Abba C, Ambroggio S, Peris C. Pregnancy, progesterone and progestins in relation to breast cancer risk. J Steroid Biochem Mol Biol 2005; 97: 441-50.
- Sonnet E, Lacut K, Roudaut N et al. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results froma randomized placebo-controlled study. Clin Endocrinol 2007; 66: 626-31.
- Campagnoli C, Ambroggio S, Lotano MR, Peris C. Progestogen use in women approaching the menopause and breast cancer risk. Maturitas. 2009; 62 (4): 4230-338.
- Davison SL, Bell R, Donath S et al. Androgen levels in adult females: Changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005; 90: 3847-53.
- Attar E. Aromatase and other steroidogenic genes in endometriosis: translational aspects// Hum. Reprod Update 2006; 12: 49-56.
- Davis SR, Nijland EA. Pharmacological therapy for female sexual dysfunction: Has progress been made? Drugs 2008; 68: 259-64.
- Drillich A, Davis SR. Androgen therapy in women: What we think we know. Exp Gerontol 2007; 42: 457-62.
- Maia H, Casoy J, Valenle J. Testosterone replacement therapy in climacteric: benefits beyond sexuality. Gynecol Endocrin 2009; 25 (1): 12-20.
- Sarrel P, Dobay В, Wiita В. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-alone therapy. J Reprod Med 1998; 43: 847-56.
- Appeiioo MS, Midden M, van der Stege et al. Vaginal application of testosterone: a study on pharmacokinetics and the sexual response in healthy volunteers. J Sex Med 2006; 3: 541-9.
- Berman JE, Almeida FG, Jolin J et al. Correlation of androgen receptors, aromatase and 5-a reductase in the human vagina with menopausal status. Fertil Steril 2003; 79: 925-31.
- Kiaia Jr, Pimentel K, Casoy J, Athayde C. Should tibolone be used in the perimeno-pause to treat androgen deficiency. Abstract book of World Congress on Controversies in Obstetrics and Gynecology. Barcelona (Spain), 2007.
- Odmark IS, Carlstrom K, Jonsson В, Jonasson AF. Conjugated estrogen/progestogen versus tibolone hormone replacement therapy in postmenopausal women. Effects on carbohydrate metabolism and scrum sex hormone binding globulin. Maturitas 2006; 53: 89-96.
- Braunstein GD. Safety of testosterone treatment in postmenopausal women. Fertil Steril 2007; 88: 1-17.
- Shifren JL, Davis SR, Moreau HI et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: Results from the INTIMATE NM1 Study. Menopause 2006; 13: 770-9.
- Braunstein GD, Sundwall DA, Kate A et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: randomized placebo-controlled trial. Arch Intern Med 2005: 165: 1582-9.
- Buster JE, Kingsberg SA, Aguirre O et al. Testosterone patch for low sexual desirein surgically menopausal women: A randomized trial. Obstet Gynecol 2005; 105: 944-52.
- Simon J, Braunstein G, Nachtigall L et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005; 90: 5226-33.
- Davis SR, Bouchard C, Kroll R et al. The effect of a testosterone transdermal system on hypoactive sexual desire disorder in postmenopausal women not receiving systemic estrogen therapy, the aphrodite study. 82 Annual Meeting of the Endocrine Society. Boston (USA), 2006.
- Basaria S, Nguyen Т, Rosenson RS, Dobs AS. Effect of methyl testosterone administration on plasma viscosity in postmenopausal women. Clin Endocrinol (Oxf.) 2002; 57: 209-14.
- Lukanova A, Lundin E, Micheli A et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 2004; 108: 425-32.
- Somboonporn W, Davis SR. Postmenopausal testosterone therapy and breast cancer risk, Maturitas 2004; 49: 267-75.
- Labrie F, Ittu TW, Labrie С et al. Endocrine and intracrine sources of androgens in women: Inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 2003; 24: 152-82.
- Tamimi RM, Hankinson SE, Chen WY et al. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Arch Intern Med 2006; 166: 1480-3.
- Bitzer, Kenemans P, Mueck AQ. Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy. Maturitas 2008; 59: 209-18.
- Dimitrakakis, Jones RA Liu A, Bandy CA. Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy. Menopause 2004; 11: 531-5.
- Shufelt CL, Braunstein GD. Testosterone and the breast. Menopause Int 2008; 14: 117-22.